{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:55:20Z","timestamp":1790668520843,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Science and ICT","award":["RS-2025-16072897"],"award-info":[{"award-number":["RS-2025-16072897"]}],"id":[{"id":"https:\/\/ror.org\/01wpjm123","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["03-2024-0040"],"award-info":[{"award-number":["03-2024-0040"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seoul National University","id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Premature ovarian insufficiency (POI) is a reproductive disorder characterized by the early loss of ovarian function before the age of 40, resulting in infertility and increasing the long-term risk of health issues such as osteoporosis, cardiovascular disease, and neuropsychological disorders. Although many studies have been conducted to understand POI pathophysiology and to develop regenerative therapies, the effectiveness of these therapies in restoring ovarian function remains limited. This review provides a comprehensive evaluation of the establishment of animal models of POI and assesses their similarity to clinical manifestations and therapeutic outcomes observed in human patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Published preclinical and clinical studies investigating POI animal models and regenerative therapies were comprehensively reviewed. Animal models were compared with human POI in terms of pathological features, endocrine changes, and therapeutic responsiveness. Evidence from studies of mesenchymal stem cell (MSC)-based therapies, stem cell-derived extracellular vehicles (EVs), platelet-rich plasma (PRP), and scaff old-assisted combination therapies was integrated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>POI models induced by chemotherapeutic agents, autoimmune mechanisms, or oxidative stress reproduce POI features, including follicular depletion, disrupted estrous cycles, and altered hormone profiles. However, they do not fully capture the systemic progression of the condition that is observed in human patients. We summarize emerging regenerative treatment strategies, including mesenchymal stem cell-based therapies, stem cell-derived exosome-like extracellular vesicles (EVs), platelet-rich plasma, and scaffold-assisted combination therapies, combining findings from both preclinical experiments and clinical studies. Comparing shared outcome markers, such as estradiol levels and follicle counts, while emphasizing age- and duration-of-amenorrhea differences in treatment response, is critical for assessing therapeutic efficacy, with younger patients and those with shorter disease duration showing more favorable responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Current rodent models provide valuable insights but have limited ability to predict clinical efficacy. Further POI research should prioritize the development of more physiologically relevant models, such as non-human primates, which more closely resemble humans in both reproductive endocrinology and aging, omics approaches, and artificial intelligence (AI), which may significantly enhance the translational accuracy of POI research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13770-026-00834-0","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:29:03Z","timestamp":1790659743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Status of Animal Models for Premature Ovarian Insufficiency: Similarities to Clinical Manifestations and Therapeutic Applications"],"prefix":"10.1007","author":[{"given":"Bunnith","family":"Theng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yup","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"834_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41572-024-00547-5","volume":"10","author":"P Touraine","year":"2024","unstructured":"Touraine P, Chabbert-Buffet N, Plu-Bureau G, Duranteau L, Sinclair AH, Tucker EJ. Premature ovarian insufficiency. Nat Rev Dis Primers. 2024;10:63.","journal-title":"Nat Rev Dis Primers"},{"key":"834_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13697137.2022.2153033","volume":"26","author":"M Li","year":"2023","unstructured":"Li M, Zhu Y, Wei J, Chen L, Chen S, Lai D. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis. Climacteric. 2023;26:95\u2013102.","journal-title":"Climacteric"},{"key":"834_CR3","volume":"14","author":"A Sharma","year":"2022","unstructured":"Sharma A, Shrivastava D. Psychological problems related to infertility. Cureus. 2022;14:e30320.","journal-title":"Cureus"},{"key":"834_CR4","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.3390\/jcm14124210","volume":"14","author":"S Csehely","year":"2025","unstructured":"Csehely S, Kun A, Orb\u00e1n E, Katona T, Orosz M, Herman T, et al. Prevalence of Impaired bone health in premature ovarian insufficiency and early menopause and the impact of time to diagnosis. J Clin Med. 2025;14:4210.","journal-title":"J Clin Med"},{"key":"834_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70111","volume":"21","author":"S Yuan","year":"2025","unstructured":"Yuan S, Gong Y, Zhang Y, Cao W, Wei L, Sun T, et al. Brain structural alterations in young women with premature ovarian insufficiency: Implications for dementia risk. Alzheimers Dement. 2025;21:e70111.","journal-title":"Alzheimers Dement (in eng)"},{"key":"834_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ydbio.2008.06.017","volume":"321","author":"GB John","year":"2008","unstructured":"John GB, Gallardo TD, Shirley LJ, Castrillon DH. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol. 2008;321:197\u2013204.","journal-title":"Dev Biol"},{"key":"834_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.730196","volume":"12","author":"L Li","year":"2021","unstructured":"Li L, Shi X, Shi Y, Wang Z. The signaling pathways involved in ovarian follicle development. Front Physiol. 2021;12:730196.","journal-title":"Front Physiol (in eng)"},{"key":"834_CR8","first-page":"R137","volume":"150","author":"JA Hernandez Gifford","year":"2015","unstructured":"Hernandez Gifford JA. The role of WNT signaling in adult ovarian folliculogenesis. Reproduction. 2015;150:R137\u201348.","journal-title":"Reproduction (in eng)"},{"key":"834_CR9","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1096\/fj.201901791R","volume":"34","author":"N Sekulovski","year":"2020","unstructured":"Sekulovski N, Whorton AE, Shi M, Hayashi K, MacLean JA II. Periovulatory insulin signaling is essential for ovulation, granulosa cell differentiation, and female fertility. FASEB J. 2020;34:2376\u201391.","journal-title":"FASEB J"},{"key":"834_CR10","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s12015-025-10944-2","volume":"21","author":"N Hassan","year":"2025","unstructured":"Hassan N, Hussein DM, Malak FA, Abdelaziz MA, Boushra MI, Shaalan W, et al. Mesenchymal stem cells: a therapeutic approach in fertility restoration in premature ovarian insufficiency. Stem Cell Reviews and Reports. 2025;21:2089\u2013102.","journal-title":"Stem Cell Reviews and Reports"},{"key":"834_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/GCO.0000000000000784","volume":"34","author":"NS Herlihy","year":"2022","unstructured":"Herlihy NS, Seli E. The use of intraovarian injection of autologous platelet rich plasma (PRP) in patients with poor ovarian response and premature ovarian insufficiency. Curr Opin Obstet Gynecol. 2022;34:133\u20137.","journal-title":"Curr Opin Obstet Gynecol (in eng)"},{"key":"834_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13048-025-01813-0","volume":"18","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang S. Current status and future prospects of mesenchymal stem cell-derived exosomes therapy for premature ovarian insufficiency. J Ovarian Res. 2025;18:231.","journal-title":"J Ovarian Res (in eng)"},{"key":"834_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ame2.12477","volume":"7","author":"N Pouladvand","year":"2024","unstructured":"Pouladvand N, Azarnia M, Zeinali H, Fathi R, Tavana S. An overview of different methods to establish a murine premature ovarian failure model. Animal Model Exp Med. 2024;7:835\u201352.","journal-title":"Animal Model Exp Med (in eng)"},{"key":"834_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00404-023-07062-0","volume":"309","author":"L Hu","year":"2024","unstructured":"Hu L, Tan R, He Y, Wang H, Pu D, Wu J. Stem cell therapy for premature ovarian insufficiency: a systematic review and meta-analysis of animal and clinical studies. Arch Gynecol Obstet. 2024;309:457\u201367.","journal-title":"Arch Gynecol Obstet (in eng)"},{"key":"834_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051257","author":"E Moustakli","year":"2025","unstructured":"Moustakli E, Potiris A, Zikopoulos A, Zachariou A, Topis S, Panagopoulos P, et al. Platelet-rich plasma (PRP) in reproductive medicine: a critical review of PRP therapy in low-reserve and premature ovarian insufficiency. Biomedicines. 2025;13:1257.","journal-title":"Biomedicines"},{"key":"834_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04569-y","volume":"16","author":"G Ziwei","year":"2025","unstructured":"Ziwei G, Shuang N, Di W, Li j. Optimal transplantation strategies for stem cell treatment in premature ovarian failure: a network meta-analysis. Stem Cell Res Ther. 2025;16:461.","journal-title":"Stem Cell Res Ther"},{"key":"834_CR17","doi-asserted-by":"crossref","unstructured":"POI TEGGo, Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE Guideline: management of women with premature ovarian insufficiency\u2020. Human Reproduction 2016;31:926\u201337.","DOI":"10.1093\/humrep\/dew027"},{"key":"834_CR18","doi-asserted-by":"crossref","unstructured":"Kapoor E. Premature ovarian insufficiency. Curr Opin Endocr Metab Res. 2023;28:100435.","DOI":"10.1016\/j.coemr.2023.100435"},{"key":"834_CR19","first-page":"210","volume":"15","author":"B Komorowska","year":"2016","unstructured":"Komorowska B. Autoimmune premature ovarian failure. Prz Menopauzalny. 2016;15:210\u20134.","journal-title":"Prz Menopauzalny"},{"key":"834_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/GCO.0000000000000177","volume":"27","author":"EM Bilgin","year":"2015","unstructured":"Bilgin EM, Kovanci E. Genetics of premature ovarian failure. Curr Opin Obstet Gynecol. 2015;27:167\u201374.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"834_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-animal-111523-102259","volume":"13","author":"M Bellingham","year":"2025","unstructured":"Bellingham M, Evans NP, Lea RG, Padmanabhan V, Sinclair KD. Reproductive and metabolic health following exposure to environmental chemicals: mechanistic insights from mammalian models. Annu Rev Anim Biosci. 2025;13:411\u201340.","journal-title":"Annu Rev Anim Biosci (in eng)"},{"key":"834_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.theriogenology.2007.09.011","volume":"69","author":"EM Carnevale","year":"2008","unstructured":"Carnevale EM. The mare model for follicular maturation and reproductive aging in the woman. Theriogenology. 2008;69:23\u201330.","journal-title":"Theriogenology"},{"key":"834_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41586-024-08244-9","volume":"637","author":"THH Coorens","year":"2025","unstructured":"Coorens THH, et al. The human and non-human primate developmental GTEx projects. Nature. 2025;637:557\u201364.","journal-title":"Nature"},{"key":"834_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/dev.21360","volume":"58","author":"N Schultz-Darken","year":"2016","unstructured":"Schultz-Darken N, Braun KM, Emborg ME. Neurobehavioral development of common marmoset monkeys. Dev Psychobiol. 2016;58:141\u201358.","journal-title":"Dev Psychobiol"},{"key":"834_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13293-025-00771-y","volume":"16","author":"AS Meakin","year":"2025","unstructured":"Meakin AS, et al. Sexually dimorphic responses in androgen metabolism and signalling in the non-human primate placenta to moderate maternal undernutrition. Biol Sex Differ. 2025;16:93.","journal-title":"Biol Sex Differ"},{"key":"834_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s43088-025-00604-2","volume":"14","author":"A Atwa","year":"2025","unstructured":"Atwa A, Sobhy N, Latif AKMA, Bakry S. Mitigation of cyclophosphamide-induced premature ovarian insufficiency in rats through bone marrow-derived mesenchymal stem cells and placental extract therapy: a comprehensive evaluation. Beni-Suef Univ J Basic Appl Sci. 2025;14:15.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"834_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/09603271251350802","volume":"44","author":"Y Pan","year":"2025","unstructured":"Pan Y, Zeng X, Rong X, Xu Y. Luteolin alleviates cyclophosphamide-induced premature ovarian failure in rats by regulating RNF8\/HDAC2. Hum Exp Toxicol. 2025;44:09603271251350802.","journal-title":"Hum Exp Toxicol"},{"key":"834_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1089\/scd.2025.0027","volume":"34","author":"SY Lee","year":"2025","unstructured":"Lee SY, Bharti D, Lee WJ, Son YB, Jin YB, Lee HJ, et al. Treatment of premature ovarian failure mouse model using granulosa-like cells derived from Wharton\u2019s jelly-mesenchymal stem cells. Stem Cells Dev. 2025;34:214\u201325.","journal-title":"Stem Cells Dev"},{"key":"834_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13287-020-01769-6","volume":"11","author":"SY Yoon","year":"2020","unstructured":"Yoon SY, Yoon JA, Park M, Shin EY, Jung S, Lee JE, et al. Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice. Stem Cell Res Ther. 2020;11:255.","journal-title":"Stem Cell Res Ther"},{"key":"834_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7827-8-20","volume":"8","author":"I Ben-Aharon","year":"2010","unstructured":"Ben-Aharon I, Bar-Joseph H, Tzarfaty G, Kuchinsky L, Rizel S, Stemmer SM, et al. Doxorubicin-induced ovarian toxicity. Reprod Biol Endocrinol. 2010;8:20.","journal-title":"Reprod Biol Endocrinol"},{"key":"834_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3249495","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wei Q, Wang H, Han L, Dai H, Qian X, et al. Mesenchymal stem cell therapy using human umbilical cord in a rat model of autoimmune-induced premature ovarian failure. Stem Cells Int. 2020;2020:3249495.","journal-title":"Stem Cells Int"},{"key":"834_CR32","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/humrep\/deac014","volume":"37","author":"H Silv\u00e9n","year":"2022","unstructured":"Silv\u00e9n H, Savukoski SM, Pesonen P, Pukkala E, Gissler M, Suvanto E, et al. Incidence and familial risk of premature ovarian insufficiency in the Finnish female population. Hum Reprod. 2022;37:1030\u20136.","journal-title":"Hum Reprod"},{"key":"834_CR33","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.1080\/21655979.2021.2005991","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Li X, Deng L. Chrysin reduces inflammation and oxidative stress and improves ovarian function in D-gal-induced premature ovarian failure. Bioengineered. 2022;13:8291\u2013301.","journal-title":"Bioengineered"},{"key":"834_CR34","first-page":"144","volume":"7","author":"XY Chen","year":"2014","unstructured":"Chen XY, Gu C, Ma M, Cong Q, Guo T, Ma D, et al. A mouse model of premature ovarian insufficiency induced by tripterygium glycoside via subcutaneous injection. Int J Clin Exp Pathol. 2014;7:144\u201351.","journal-title":"Int J Clin Exp Pathol"},{"key":"834_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100730","volume":"45","author":"A Cattoni","year":"2021","unstructured":"Cattoni A, Parissone F, Porcari I, Molinari S, Masera N, Franchi M, et al. Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: practical recommendations. Blood Rev. 2021;45:100730.","journal-title":"Blood Rev"},{"key":"834_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123961","author":"A Podfigurna","year":"2020","unstructured":"Podfigurna A, Maciejewska-Jeske M, Nadolna M, Mikolajska-Ptas P, Szeliga A, Bilinski P, et al. Impact of hormonal replacement therapy on bone mineral density in premature ovarian insufficiency patients. J Clin Med. 2020;9:3961.","journal-title":"J Clin Med"},{"key":"834_CR37","first-page":"47","volume":"9","author":"F Akbari Asbagh","year":"2011","unstructured":"Akbari Asbagh F, Ebrahimi M. A case report of spontaneous pregnancy during hormonal replacement therapy for premature ovarian failure. Iran J Reprod Med. 2011;9:47\u20139.","journal-title":"Iran J Reprod Med"},{"key":"834_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bpobgyn.2008.10.008","volume":"23","author":"N Panay","year":"2009","unstructured":"Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol. 2009;23:129\u201340.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"834_CR39","doi-asserted-by":"crossref","unstructured":"Webber L, Anderson RA, Davies M, Janse F, Vermeulen N. HRT for women with premature ovarian insufficiency: a comprehensive review. Hum Reprod Open. 2017;2017:hox007.","DOI":"10.1093\/hropen\/hox007"},{"key":"834_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6940283","author":"RS Mahla","year":"2016","unstructured":"Mahla RS. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016;2016:6940283.","journal-title":"Int J Cell Biol"},{"key":"834_CR41","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.7150\/thno.102641","volume":"14","author":"Z Yuan","year":"2024","unstructured":"Yuan Z, Zhang Y, He X, Wang X, Wang X, Ren S, et al. Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies. Theranostics. 2024;14:6487\u2013515.","journal-title":"Theranostics"},{"key":"834_CR42","doi-asserted-by":"crossref","unstructured":"Oubari H, Berkane Y, Jeljeli M, Lellouch AG, Smadja DM. Engineering the future of stem cells in vascular reconstruction: a leap towards functional endothelialized tissue-engineered vascular conduits. Stem Cell Rev Rep. 2025;21:2796\u2013806.","DOI":"10.1007\/s12015-025-10968-8"},{"key":"834_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043008","volume":"104","author":"Y Xing","year":"2025","unstructured":"Xing Y, Huang Z, Cao L. Application of tissue engineering in wound healing: a 20-year bibliometric and visualized study. Medicine (Baltimore). 2025;104:e43008.","journal-title":"Medicine (Baltimore)"},{"key":"834_CR44","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/term.2870","volume":"13","author":"E Cho","year":"2019","unstructured":"Cho E, Kim YY, Noh K, Ku SY. A new possibility in fertility preservation: the artificial ovary. J Tissue Eng Regen Med. 2019;13:1294\u2013315.","journal-title":"J Tissue Eng Regen Med"},{"key":"834_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03018-z","volume":"30","author":"FM Moraddahande","year":"2025","unstructured":"Moraddahande FM, Meybodi SME, Matin M, Soleimani N, Ghasemzadeh N, Firoozabadi AD. Current status and new horizons in stem cell therapy in cardiovascular regenerative medicine (CaVaReM): an update. Eur J Med Res. 2025;30:837.","journal-title":"Eur J Med Res"},{"key":"834_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020249","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Sakata N, Yoshimatsu G, Hasegawa S, Kodama S. Regenerative and transplantation medicine: cellular therapy using adipose tissue-derived mesenchymal stromal cells for type 1 diabetes mellitus. J Clin Med. 2019;8:249.","journal-title":"J Clin Med"},{"key":"834_CR47","first-page":"1399","volume":"54","author":"M Shojapour","year":"2025","unstructured":"Shojapour M, Asgharzade S. Regenerative medicine in the treatment of Alzheimer\u2019s disease: a narrative review. Iran J Public Health. 2025;54:1399\u2013410.","journal-title":"Iran J Public Health"},{"key":"834_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/5584_2022_719","volume-title":"Cell biology and translational medicine, volume 17: stem cells in tissue differentiation, regulation and disease","author":"CHC Sukowati","year":"2022","unstructured":"Sukowati CHC, Tiribelli C. Adult stem cell therapy as regenerative medicine for end-stage liver disease. In: Turksen K, editor. Cell biology and translational medicine, volume 17: stem cells in tissue differentiation, regulation and disease. Cham: Springer Nature Switzerland; 2022. p. 57\u201372."},{"key":"834_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13577-022-00795-1","volume":"36","author":"A Naeem","year":"2023","unstructured":"Naeem A, Gupta N, Naeem U, Elrayess MA, Albanese C. Amniotic stem cells as a source of regenerative medicine to treat female infertility. Hum Cell. 2023;36:15\u201325.","journal-title":"Hum Cell"},{"key":"834_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/ten.teb.2023.0094","volume":"30","author":"Y-X Li","year":"2024","unstructured":"Li YX, Wei SQ, Li S, Zheng PS. Strategies and challenges of mesenchymal stem cells-derived extracellular vesicles in infertility. Tissue Eng Part B Rev. 2024;30:385\u2013403.","journal-title":"Tissue Eng Part B Rev"},{"key":"834_CR51","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12015-022-10493-y","volume":"19","author":"A Umer","year":"2023","unstructured":"Umer A, Khan N, Greene DL, Habiba UE, Shamim S, Khayam AU, et al. The therapeutic potential of human umbilical cord derived mesenchymal stem cells for the treatment of premature ovarian failure. Stem Cell Rev Rep. 2023;19:651\u201366.","journal-title":"Stem Cell Rev Rep"},{"key":"834_CR52","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s43032-025-01942-3","volume":"32","author":"A Jafarzade","year":"2025","unstructured":"Jafarzade A, Anadol E, \u00c7aydere M, Burgucu D, Y\u0131lmaz C, Ergi\u015fi S, et al. Investigation of the efficacy of umbilical cord mesenchymal stem cell and melatonin treatment in premature ovarian failure model. Reprod Sci. 2025;32:2985\u201396.","journal-title":"Reprod Sci"},{"key":"834_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9:27.","journal-title":"Signal Transduct Target Ther"},{"key":"834_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13048-025-01785-1","volume":"18","author":"X Cui","year":"2025","unstructured":"Cui X, Li H, Huang X, Xue T, Wang S, Zhu X, et al. Exosomes derived from mesenchymal stem cells repair ovarian function by suppressing NLRP3-mediated pyroptosis in cyclophosphamide-induced premature ovarian failure. J Ovarian Res. 2025;18:216.","journal-title":"J Ovarian Res"},{"key":"834_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/endocrines2010002","volume":"2","author":"TKC Vo","year":"2021","unstructured":"Vo TKC, Tanaka Y, Kawamura K. Ovarian rejuvenation using autologous platelet-rich plasma. Endocrines. 2021;2:15\u201327.","journal-title":"Endocrines"},{"key":"834_CR56","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.18632\/aging.206099","volume":"16","author":"M Cozzolino","year":"2024","unstructured":"Cozzolino M, Ergun Y, Seli DA, Herraiz S. Intraovarian PRP injection improves oocyte quality and early embryo development in mouse models of chemotherapy-induced diminished ovarian reserve. Aging (Albany NY). 2024;16:12123\u201337.","journal-title":"Aging (Albany NY)"},{"key":"834_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12958-020-00638-4","volume":"18","author":"S Ahmadian","year":"2020","unstructured":"Ahmadian S, Sheshpari S, Pazhang M, Miranda Bedate A, Beheshti R, Mesgari Abbasi M, et al. Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation. Reprod Biol Endocrinol. 2020;18:78.","journal-title":"Reprod Biol Endocrinol"},{"key":"834_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12938","volume":"53","author":"L Yan","year":"2020","unstructured":"Yan L, Wu Y, Li L, Wu J, Zhao F, Gao Z, et al. Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency. Cell Prolif. 2020;53:e12938.","journal-title":"Cell Prolif"},{"key":"834_CR59","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s11427-017-9272-2","volume":"61","author":"L Ding","year":"2018","unstructured":"Ding L, Yan G, Wang B, Xu L, Gu Y, Ru T, et al. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci. 2018;61:1554\u201365.","journal-title":"Sci China Life Sci"},{"key":"834_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.arcmed.2022.12.015","volume":"54","author":"S Zafardoust","year":"2023","unstructured":"Zafardoust S, Kazemnejad S, Darzi M, Fathi-Kazerooni M, Saffarian Z, Khalili N, et al. Intraovarian administration of autologous menstrual blood derived-mesenchymal stromal cells in women with premature ovarian failure. Arch Med Res. 2023;54:135\u201344.","journal-title":"Arch Med Res"},{"key":"834_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-093804","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu H, Lou Y, Li J, Liu C, Zhang H, et al. Efficacy and safety of autologous adipose tissue-derived stromal vascular fraction in patients with premature ovarian insufficiency: protocol for a single-centre randomised controlled trial. BMJ Open. 2025;15:e093804.","journal-title":"BMJ Open"},{"key":"834_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102744","volume":"74","author":"L Weng","year":"2024","unstructured":"Weng L, Wei L, Zhang Q, Sun T, Kuang X, Huang Q, et al. Safety and efficacy of allogenic human amniotic epithelial cells transplantation via ovarian artery in patients with premature ovarian failure: a single-arm, phase 1 clinical trial. EClinicalMedicine. 2024;74:102744.","journal-title":"EClinicalMedicine"},{"key":"834_CR63","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.reth.2025.06.007","volume":"30","author":"C Navarro","year":"2025","unstructured":"Navarro C, Torrecillas Cabrera P, Teppa Garran A. Comparative analysis of the use of autologous exosomes and platelet-derived growth factors in women with premature ovarian insufficiency and infertility: a prospective, randomized, observational, analytical study. Regen Ther. 2025;30:309\u201320.","journal-title":"Regen Ther"},{"key":"834_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061809","author":"K Sfakianoudis","year":"2020","unstructured":"Sfakianoudis K, Simopoulou M, Grigoriadis S, Pantou A, Tsioulou P, Maziotis E, et al. Reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women. J Clin Med. 2020;9:1809.","journal-title":"J Clin Med"},{"key":"834_CR65","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1177\/0963689719859539","volume":"28","author":"K Pantos","year":"2019","unstructured":"Pantos K, Simopoulou M, Pantou A, Rapani A, Tsioulou P, Nitsos N, et al. A case series on natural conceptions resulting in ongoing pregnancies in menopausal and prematurely menopausal women following platelet-rich plasma treatment. Cell Transplant. 2019;28:1333\u201340.","journal-title":"Cell Transplant"},{"key":"834_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fendo.2020.00050","volume":"11","author":"CC Hsu","year":"2020","unstructured":"Hsu CC, Hsu L, Hsu I, Chiu YJ, Dorjee S. Live birth in woman with premature ovarian insufficiency receiving ovarian administration of platelet-rich plasma (PRP) in combination with gonadotropin: a case report. Front Endocrinol (Lausanne). 2020;11:50.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"834_CR67","first-page":"1571","volume":"17","author":"A Santamaria","year":"2025","unstructured":"Santamaria A, Ballester A, Mu\u00f1oz M. Enhancing oocyte activation in women with ovarian failure: clinical outcomes of the Stem Cell Regenera study using G-CSF mobilization of peripheral blood stem cells and intraovarian injection of stem cell factor-enriched platelet rich plasma in real-world-practice. Aging (Albany NY). 2025;17:1571\u201380.","journal-title":"Aging (Albany NY)"},{"key":"834_CR68","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4252\/wjsc.v12.i8.857","volume":"12","author":"K Bahrehbar","year":"2020","unstructured":"Bahrehbar K, Rezazadeh Valojerdi M, Esfandiari F, Fathi R, Hassani SN, Baharvand H. Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure. World J Stem Cells. 2020;12:857\u201378.","journal-title":"World J Stem Cells"},{"key":"834_CR69","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jrhm.2016.09.002","volume":"2","author":"D Ghosh","year":"2016","unstructured":"Ghosh D, Mehta N, Patil A, Sengupta J. Ethical issues in biomedical use of human embryonic stem cells (hESCs). J Reprod Health Med. 2016;2:S37\u201347.","journal-title":"J Reprod Health Med"},{"key":"834_CR70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12015-018-9867-0","volume":"15","author":"P Feng","year":"2019","unstructured":"Feng P, Li P, Tan J. Human menstrual blood-derived stromal cells promote recovery of premature ovarian insufficiency via regulating the ECM-dependent FAK\/AKT signaling. Stem Cell Rev Rep. 2019;15:241\u201355.","journal-title":"Stem Cell Rev Rep"},{"key":"834_CR71","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/IJWH.S134074","volume":"9","author":"A Badawy","year":"2017","unstructured":"Badawy A, Sobh MA, Ahdy M, Abdelhafez MS. Bone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse model. Int J Womens Health. 2017;9:441\u20137.","journal-title":"Int J Womens Health"},{"key":"834_CR72","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12015-023-10629-8","volume":"20","author":"WQ Ma","year":"2024","unstructured":"Ma WQ, Zhuo AP, Xiao YL, Gao M, Yang YT, Tang LC, et al. Human bone marrow derived-mesenchymal stem cells treatment for autoimmune premature ovarian insufficiency. Stem Cell Rev Rep. 2024;20:538\u201353.","journal-title":"Stem Cell Rev Rep"},{"key":"834_CR73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13256-020-02426-5","volume":"14","author":"P Igboeli","year":"2020","unstructured":"Igboeli P, El Andaloussi A, Sheikh U, Takala H, ElSharoud A, McHugh A, et al. Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature. J Med Case Rep. 2020;14:108.","journal-title":"J Med Case Rep"},{"key":"834_CR74","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dew041","volume":"31","author":"J Su","year":"2016","unstructured":"Su J, Ding L, Cheng J, Yang J, Li X, Yan G, et al. Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency. Hum Reprod. 2016;31:1075\u201386.","journal-title":"Hum Reprod"},{"key":"834_CR75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/scrt335","volume":"4","author":"F Wang","year":"2013","unstructured":"Wang F, Wang L, Yao X, Lai D, Guo L. Human amniotic epithelial cells can differentiate into granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure. Stem Cell Res Ther. 2013;4:124.","journal-title":"Stem Cell Res Ther"},{"key":"834_CR76","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s12015-024-10745-z","volume":"20","author":"X Ye","year":"2024","unstructured":"Ye X, Lin Y, Ying Y, Shen X, Ni F, Wang F, et al. Human amniotic epithelial stem cells alleviate autoimmune premature ovarian insufficiency in mice by targeting granulosa cells via AKT\/ERK pathways. Stem Cell Rev Rep. 2024;20:1618\u201335.","journal-title":"Stem Cell Rev Rep"},{"key":"834_CR77","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.2147\/IJN.S532207","volume":"20","author":"J Chen","year":"2025","unstructured":"Chen J, Huo X, Qian M, Xue Q, He Y, Xu P, et al. Exosomes derived from human mesenchymal stem cells mitigate follicular interstitial cell ferroptosis via the miR-26a-5p\/PTEN\/GPX4 axis in rats with chemotherapy-induced premature ovarian insufficiency. Int J Nanomedicine. 2025;20:10195\u2013212.","journal-title":"Int J Nanomedicine"},{"key":"834_CR78","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13287-025-04396-1","volume":"16","author":"Y Tang","year":"2025","unstructured":"Tang Y, He Y, Huo X, Chen J, Qian M, Huang H, et al. hUMSC-derived exosomes alleviate follicular interstitial cell autophagy by let-7a-5p\/AMPK\/mTOR axis in POI rats. Stem Cell Res Ther. 2025;16:291.","journal-title":"Stem Cell Res Ther"},{"key":"834_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2023.103953","volume":"158","author":"L Yuan","year":"2023","unstructured":"Yuan L, Huang W, Bi Y, Chen S, Wang X, Li T, et al. G-CSF-mobilized peripheral blood mononuclear cells combined with platelet-rich plasma restored the ovarian function of aged rats. J Reprod Immunol. 2023;158:103953.","journal-title":"J Reprod Immunol"},{"key":"834_CR80","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s13287-025-04779-4","volume":"16","author":"T Zhao","year":"2025","unstructured":"Zhao T, Xiao X, Li L, Wei Y, Shi H, Yang G, et al. Mechanism of platelet-rich plasma in improving cyclophosphamide-induced premature ovarian failure in rats. Stem Cell Res Ther. 2025;16:649.","journal-title":"Stem Cell Res Ther"},{"key":"834_CR81","doi-asserted-by":"publisher","first-page":"G49","DOI":"10.1093\/ejendo\/lvaf206","volume":"193","author":"MA Lumsden","year":"2025","unstructured":"Lumsden MA, Dekkers OM, Faubion SS, Lind\u00e9n Hirschberg A, Jayasena CN, Lambrinoudaki I, et al. European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause. Eur J Endocrinol. 2025;193:G49\u201381.","journal-title":"Eur J Endocrinol"},{"key":"834_CR82","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.fertnstert.2024.11.007","volume":"123","author":"L Yeganeh","year":"2025","unstructured":"ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI, Panay N, Anderson RA, Bennie A, Cedars M, Davies M, et al. Evidence-based guideline: premature ovarian insufficiency. Fertil Steril. 2025;123:221\u201336.","journal-title":"Fertil Steril"},{"key":"834_CR83","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41585-025-01062-2","volume":"22","author":"RC Edenfield","year":"2025","unstructured":"Edenfield RC, Bash JC, Shorey-Kendrick LE, D\u2019Mello RJ, Rice-Stitt TL, Hagen OL, et al. Non-human primates as a translational model for the study of male reproductive health. Nat Rev Urol. 2025;22:756\u201374.","journal-title":"Nat Rev Urol"},{"key":"834_CR84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s43032-023-01342-5","volume":"31","author":"YY Kim","year":"2024","unstructured":"Kim YY, Kim SW, Kim E, Kim YJ, Kang BC, Ku SY. Transcriptomic profiling of reproductive age marmoset monkey ovaries. Reprod Sci. 2024;31:81\u201395.","journal-title":"Reprod Sci"},{"key":"834_CR85","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/path.4657","volume":"238","author":"CM King","year":"2016","unstructured":"King CM, Barbara C, Prentice A, Brenton JD, Charnock-Jones DS. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma. J Pathol. 2016;238:185\u201396.","journal-title":"J Pathol (in eng)"},{"key":"834_CR86","doi-asserted-by":"publisher","first-page":"352","DOI":"10.20411\/pai.v2i3.186","volume":"2","author":"H Friedman","year":"2017","unstructured":"Friedman H, Ator N, Haigwood N, Newsome W, Allan JS, Golos TG, et al. The critical role of nonhuman primates in medical research. Pathog Immun. 2017;2:352\u201365.","journal-title":"Pathog Immun (in eng)"},{"key":"834_CR87","doi-asserted-by":"publisher","first-page":"1536750","DOI":"10.3389\/fbioe.2025.1536750","volume":"13","author":"YY Kim","year":"2025","unstructured":"Kim YY, Kwak J, Kang BC, Ku SY. Non-human primate: the new frontier model of female reproductive engineering. Front Bioeng Biotechnol. 2025;13:1536750.","journal-title":"Front Bioeng Biotechnol"},{"key":"834_CR88","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/humupd\/dmaf002","volume":"31","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhu M, Chen Y, Wang G, Yang H, Lu X, et al. Harnessing omics data for drug discovery and development in ovarian aging. Hum Reprod Update. 2025;31:240\u201368.","journal-title":"Hum Reprod Update (in eng)"},{"key":"834_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70284","volume":"28","author":"W Shi","year":"2024","unstructured":"Shi W, Wang D, Xue X, Qiao S, Zhang W, Shi J, et al. Epigenomic landscape of human cumulus cells in premature ovarian insufficiency using single-base resolution methylome and hydroxymethylome. J Cell Mol Med. 2024;28:e70284.","journal-title":"J Cell Mol Med (in eng)"},{"key":"834_CR90","doi-asserted-by":"publisher","first-page":"2528563","DOI":"10.1080\/15592294.2025.2528563","volume":"20","author":"J Li","year":"2025","unstructured":"Li J, Liao Q, Guo Y, Zhang J, Zhang R, Liu Q, et al. Mechanism of crosstalk between DNA methylation and histone acetylation and related advances in diagnosis and treatment of premature ovarian failure. Epigenetics. 2025;20:2528563.","journal-title":"Epigenetics (in eng)"},{"key":"834_CR91","doi-asserted-by":"publisher","first-page":"958","DOI":"10.12891\/ceog5022.2019","volume":"46","author":"Y Wu","year":"2019","unstructured":"Wu Y, Tong L, Xiao L. Artificial neural network models for prediction of premature ovarian failure. Clin Exp Obstet Gynecol. 2019;46:958\u201363.","journal-title":"Clin Exp Obstet Gynecol"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-026-00834-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-026-00834-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-026-00834-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:03:11Z","timestamp":1790665391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-026-00834-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":91,"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1007\/s13770-026-00834-0","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No potential conflict of interest was reported by the author(s).","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no animal experiments carried out for this article.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}